Tag: Cancer: Lung
PLCOm2012 Models Have High Sensitivity for Lung Cancer
PLCOm2012 models have higher sensitivity than USPSTF criteria, with no difference by Indigenous classification
Machine Learning Can Better ID Who Needs Lung Cancer Screening
Model relies only on age, smoking duration, and pack-years
Intensity-Modulated Radiation Therapy Best for Locally Advanced NSCLC
Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy
Reproductive Factors Linked to Risk for Lung Cancer
Early menarche, early menopause, shortened reproductive life span linked to increased risk, especially for NSCLC
Removing Race Correction From Lung Function Test Changes Clinical Management
Removal of race correction was tied to a significant reduction in the estimation of lung function for African Americans
Common Cancer Screenings May Not Extend Life Longevity
Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy
Cancer Screening Has Provided Significant Value to U.S. Population
Single-site cancer screening could save an additional 3.2 to 5.1 million life-years with perfect adherence
Atezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo
First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy
Plasma ctDNA Genotyping Can Accelerate Time to Treatment for NSCLC
Median time to treatment was 39 days for ACCELERATE cohort versus 62 days for reference cohort using standard tissue genotyping
Blood-Based Marker Plus PLCO Risk Model Can ID Lethal Lung Cancer
AUROC estimate of four-marker protein panel plus PLCOm2012 was 0.88 for risk prediction of lung cancer death
